TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·November 6, 2026

Humana Inc. (HUM) gains on earnings beats, up 4.0%

Humana Inc. (HUM) gains 4.0% after reporting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results and improved outlook.

Earnings FlashHUMHealthcareMedical - Healthcare Plans
By TickerSpark·November 6, 2026·2 min read
Humana Inc. (HUM) gains on earnings beats, up 4.0%
▌Key Takeaway
Humana Inc. (HUM) climbed 4.03% after reporting a smaller-than-expected loss of $0.70 per share versus the $1.00 loss analysts expected, while revenue came in at $41.16 billion versus $40.87 billion estimated. The beat supports near-term sentiment, but investors still need to see whether Humana can convert stronger revenue into sustained profitability.

Humana Inc. (HUM) Gains After Earnings Beat

Humana Inc. (HUM) gained 4.03% in regular-session trading to $428.39 after reporting EPS of -$0.70 versus -$1.00 expected and revenue of $41.16B versus $40.87B estimated.

Key Numbers

  • EPS: -$0.70 actual versus -$1.00 estimated, a beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $41.16B actual versus $40.87B estimated, a beat.
  • Stock reaction: HUM closed at $428.39, up 4.03% in regular-session trading.
  • Trading range: Shares moved between $411.56 and $444.00 during the session.
  • Volume: 303,475 shares traded versus a 1,244,321 average.
  • Trend: EPS exceeded estimates in each of the last five listed quarters.
  • A Dual Beat Helps, but Profitability Still Matters

    The result is a favorable near-term signal, but it is not a clean profit result. HUM still reported negative EPS. The smaller-than-expected loss and revenue beat show the quarter came in ahead of forecasts on both headline measures.

    On the earnings call, the central issue is whether management ties the $41.16B revenue result and -$0.70 EPS to repeatable operating performance. Any outlook tied to those figures would help investors judge whether this was a durable step or simply a quarter that cleared a low bar.

    Recent results provide a mixed but constructive backdrop. EPS ranged from -$3.96 to $10.31 across the five listed quarters, despite beating estimates each time. That streak supports execution against forecasts, while the wide swing argues against treating one beat as a new earnings pattern.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    HUM’s dual beat and 4.03% gain strengthen the near-term case, but negative EPS and wide recent swings keep profitability as the central test.

    Read the full HUM research report
    ▌Common Questions

    Frequently asked questions

    +Why did Humana stock go up after earnings?
    Humana Inc. (HUM) rose 4.03% because it beat both earnings and revenue estimates. The company reported EPS of -$0.70 versus -$1.00 expected and revenue of $41.16 billion versus $40.87 billion expected.
    +Did Humana beat earnings estimates this quarter?
    Yes. Humana Inc. (HUM) reported EPS of -$0.70, which was better than the -$1.00 analysts expected. It also beat on revenue, posting $41.16 billion versus the $40.87 billion estimate.
    +Is Humana profitable right now?
    No. Humana Inc. (HUM) still reported a negative EPS of -$0.70, so the company posted a loss in the quarter. The result was better than expected, but profitability remains the key issue for investors.
    +How has Humana performed versus estimates in recent quarters?
    Humana Inc. (HUM) has beaten EPS estimates in each of the last five listed quarters. However, the reported EPS has been volatile, ranging from -$3.96 to $10.31 across those periods.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on HUM?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the HUM report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full HUM research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the HUM report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on HUM

    More to read

    All articles
    Humana Inc. (HUM) gains on deep earnings beat analysis
    HUM

    Humana Inc. (HUM) gains on deep earnings beat analysis

    Humana Inc. (HUM) gained after a better-than-feared Q3 earnings beat, but the real story is the deeper recovery setup. Revenue improved sequentially, guidance rose, and management pointed to easing medical cost trends, stronger membership growth, and a clearer path to margin recovery.

    Nov 6·7 min
    Humana Inc. (HUM) jumps 16% on Medicare Advantage boost
    HUM

    Humana Inc. (HUM) jumps 16% on Medicare Advantage boost

    Humana Inc. (HUM) jumps after CMS 2027 Medicare Advantage Star Ratings showed 95% of members in plans rated 4 stars or above. The company’s flagship H5216 contract also returned to 4 stars, restoring bonus-payment eligibility and improving the outlook for revenue and margins.

    Oct 9·5 min
    Humana (HUM): Medicare Advantage Recovery in Progress
    HUM

    Humana (HUM): Medicare Advantage Recovery in Progress

    Humana’s Buy case hinges on a rebound in Medicare Advantage economics, improving operating efficiency, and CenterWell growth. The stock still faces meaningful reimbursement, Star Ratings, and medical cost risk.

    Oct 9·22 min